Federal contract award
W81XWH20C0115
SBIR PHASE III: JW190526
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W4PZ USA MED RSCH ACQUIS ACT |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN94 — OTHER MEDICAL - ENGINEERING DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $3.9M |
| Current contract value | $3.9M |
| Potential contract value / ceiling | $3.9M |
| Start date | Sep 25, 2020 |
| Current end date | Dec 30, 2024 |
| Potential end date | Dec 30, 2024 |
| Latest award activity | Nov 25, 2024 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 14 of 14 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Nov 25, 2024 | P00013 | $0 | SBIR PHASE III: JW190526 |
| May 30, 2024 | P00012 | $0 | SBIR PHASE III: JW190526 |
| Oct 26, 2023 | P00011 | $0 | SBIR PHASE III: JW190526 |
| Oct 4, 2023 | P00010 | $0 | SBIR PHASE III: JW190526 |
| Jun 13, 2023 | P00009 | $0 | SBIR PHASE III: JW190526 PSC AN94 MEDICAL R & D INTEROPERABLE AND COMPACT INFUSION PUMP MODULE FOR THE DELIVERY OF DRUGS, FLUIDS, AND BLOOD PRODUCTS AT THE POINT OF INJURY AND FOR EN ROUTE CARE, PFC, AND FSC |
| Apr 13, 2023 | P00008 | $0 | SBIR PHASE III: JW190526 PSC AN94 MEDICAL R & D INTEROPERABLE AND COMPACT INFUSION PUMP MODULE FOR THE DELIVERY OF DRUGS, FLUIDS, AND BLOOD PRODUCTS AT THE POINT OF INJURY AND FOR EN ROUTE CARE, PFC, AND FSC |
| Sep 20, 2022 | P00007 | $426.0K | SBIR PHASE III: JW190526 PSC AN94 MEDICAL R & D INTEROPERABLE AND COMPACT INFUSION PUMP MODULE FOR THE DELIVERY OF DRUGS, FLUIDS, AND BLOOD PRODUCTS AT THE POINT OF INJURY AND FOR EN ROUTE CARE, PFC, AND FSC |
| Jul 12, 2022 | P00006 | $0 | SBIR PHASE III: JW190526 |
| May 31, 2022 | P00005 | $0 | SBIR PHASE III: JW190526 |
| May 20, 2021 | P00004 | $150.5K | MEDICAL RESEARCH AND DEVELOPMENT CONTRACT SBIR PHASE III: JW190526 - MODIFICATION P00004 PROVIDE INCREMENTAL FUNDING AND REMOVED CMR REQUIREMENT. |
| Mar 30, 2021 | P00003 | $0 | MEDICAL RESEARCH AND DEVELOPMENT CONTRACT SBIR PHASE III: JW190526 - MODIFICATION P00003 INCORPORATE REVISED SOW AND BUDGET. |
| Dec 1, 2020 | P00002 | $0 | MEDICAL RESEARCH AND DEVELOPMENT CONTRACT SBIR PHASE III: JW190526 - MODIFICATION P00002 INCLUDE AUTHORIZED PRE-AWARD COSTS. |
| Oct 8, 2020 | P00001 | $0 | MEDICAL RESEARCH AND DEVELOPMENT CONTRACT SBIR PHASE III: JW190526 - MODIFICATION P00001 ADD REQUIRED CLAUSES. |
| Sep 24, 2020 | 0 | $3.3M | SBIR PHASE III: JW190526 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.